UNSPSC 51390000: Sympathomimetic or adrenergic drugs

This classification denotes drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

UNSPSC 51390000 Sympathomimetic or adrenergic drugs is a Family code capturing state and local procurement of naloxone and related emergency pharmaceutical interventions for public health initiatives. Recent solicitations show county health departments and state health agencies acquiring naloxone formulations and overdose-reversal delivery systems to support harm reduction, community health, and emergency preparedness programs. The code draws issuing bodies from county public health departments and state-level health and human services agencies, with purchasing driven by community health directors and pharmacy benefit managers managing prescription fulfillment and medication distribution.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to solicit vendor capabilities regarding direct-to-manufacturer prescription programs and pharmacy benefit contracting, seeking information on vendor experience with self-insured employer and government health plans and capacity to negotiate net pricing arrangements without rebates. Geographic activity centers on Florida and Texas, with broader potential engagement across state health agencies managing Medicaid, CHIP, and employee health benefit programs.